SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

Open Letter to FDA Commissioner: Investigate Gardasil Clinical Trials

By 143 Comments

The following open letter to FDA Commissioner, Dr. Scott Gottlieb, calling for immediate investigations into many facets of the clinical trials for Gardasil sponsored by Merck was emailed today. If you support this request, please leave a note in the comment section below that includes your name, title, and organization. Help the FDA understand how […]

[Continue reading...]

HPV vaccine is neither safe nor effective

By 2 Comments

The following letter to the editor of The Baltimore Sun  was written by Emily Tarsell and Dr. William Reichel. It is reprinted below with their permission. August 9, 2015  Dear Editor: Your recent article in The Baltimore Sun, Medicine Briefs for August 2, 2015, states that “not enough pediatricians are strongly recommending HPV vaccine.” It appears […]

[Continue reading...]

How the FDA responds to Gardasil Injuries

By 2 Comments

Correspondence between Gardasil Parents and the FDA Kim and Chad Robinson’s nightmare began on September 2, 2010. That was the day their daughter, Katie, received her first and only injection of Gardasil. Katie’s health began to deteriorate almost immediately. Like so many others, she developed Dysautonomia (POTS), food sensitivities/allergies, autoimmune disorders and a host of other […]

[Continue reading...]

The HPV vaccine debate is over?

By Leave a Comment

Debate [SaneVax:  The proponents of mass HPV vaccination programs and government health officials do not seem to understand science and medicine are constantly evolving. Treatments and medications which were heralded as miracles, often have dark consequences revealed after decades of use….antibiotics are a prime example. HPV vaccines have not been studied for long term efficacy, […]

[Continue reading...]

SaneVax Open Letter to Margaret Hamburg: When was the FDA informed of viral DNA in Gardasil?

By 7 Comments

Sanevax square

    The Honorable Margaret A. Hamburg, M.D., Commissioner                                                       September 10, 2012 U. S. Food and Drug Administration (FDA) 10903 New Hampshire Ave. Silver Spring MD 20993-0002   Dear Dr. Hamburg: In a public announcement, the FDA stated: “Since the early development of Gardasil, FDA and the manufacturer (Merck and Co., Inc.) have known […]

[Continue reading...]

SaneVax Open Letter to Kathleen Sebelius, Secretary of Health and Human Services

By 15 Comments

31 January 2012, Open Letter To:  Kathleen Sebelius, Secretary of Health and Human Services – Kathleen.Sebelius@hhs.gov Subject: Rescind approval of Gardasil® due to lack of efficacy during post-licensure monitoring Dear Ms. Sebelius: The quadrivalent human papillomavirus (HPV) vaccine, Gardasil® was approved for marketing as a drug to prevent cervical cancer under the fast track drug […]

[Continue reading...]

SANE Vax to FDA: Recombinant HPV DNA found in multiple samples of Gardasil

By 138 Comments

         The Honorable Margaret A. Hamburg, M.D., Commissioner U. S. Food and Drug Administration (FDA) 10903 New Hampshire Ave. Silver Spring MD 20993-0002August 29, 2011 Dear Dr. Hamburg: At the request of medical consumers concerned about HPV vaccine safety and efficacy, SANE Vax Inc. has retained a private laboratory to test a […]

[Continue reading...]

SANE Vax to CDC: Request for additional data on HPV vaccine post-marketing monitoring

By 1 Comment

Lauri Markowitz, M.D. Centers for Disease Control and Prevention MS E05, 1600 Clifton Road Atlanta, GA 30333 lem2@cdc.govAugust 31, 2011 Dear Dr. Markowitz: Thank you for your August 29, 2011 response to my letter requesting additional information about post licensure monitoring for Gardasil™ from the CDC. Before relaying your response to medical consumers, I would […]

[Continue reading...]

SANE Vax to CDC: Request for post-HPV vaccination monitoring data

By 1 Comment

Lauri Markowitz, M.D.  Centers for Disease Control and Prevention MS E05, 1600 Clifton Road Atlanta, GA 30333 lem2@cdc.gov July 26, 2011 Dear Dr. Markowitz: Thank you for your letter dated July 14, 2011 in response to the SaneVax Inc. letter of  28 May 2011, concerning the post-licensure monitoring project on Gardasil™, which was approved for marketing […]

[Continue reading...]

SANE Vax to Dr. Mark Schiffman: HPV Vaccine Accountability

By 1 Comment

  Mark Schiffman, M.D., M.P.H. Senior Investigator, National Cancer Institute Executive Plaza South, Room 5026 6120 Executive Boulevard Bethesda, Maryland 20892-7335  301-435-3983 301-402-0916 schiffmm@mail.nih.gov  Dear Dr. Schiffman: Since you are the first scientific officer to promote mass HPV vaccination of women as a means to prevent cervical cancer [1], and have been working with the […]

[Continue reading...]

SANE Vax to Senator Grassley: Congratulations, keep on investigating

By 3 Comments

Dear Senator Grassley: The SaneVax Team read your October 22, 2010 letter to Dr. Harold E. Varmus, director of the National Cancer Institute (NCI), with great interest. We would like to congratulate you on your efforts to examine the ethical questions raised by NCI employees accepting extensive travel sponsored by private companies. NCI is the […]

[Continue reading...]

Congressman Charlie A. Wilson to FDA: Gardasil Concerns

By 2 Comments

Dear Ms. Stephens, Thank you for your response to my recent inquiry into the safety and effectiveness of the HPV vaccine, Gardasil. I have studied your letter thoroughly and frankly, am somewhat disturbed by the fact that your response gives rise to more questions than answers. The following quotes from your letter raise these questions: […]

[Continue reading...]

SANE Vax to NCI/FDA: Request for reliable HPV genotyping test for medical consumers

By Leave a Comment

November 2, 2010 The Honorable Margaret Hamburg, M.D., Commissioner, FDA The Honorable Harold E. Varmus, M.D., Director,NCI  Subject: Request recommending a reliable human papillomavirus (HPV) genotyping test to support the national virology-based cervical cancer prevention program for patient care Dear Dr. Hamburg and Dr. Varmus: A recently published letter to the editor of ‘Obstetrics and […]

[Continue reading...]

SANE Vax to Margaret Hamburg: request the FDA rescind Gardasil approval

By 2 Comments

            The Honorable Margaret A. Hamburg, M.D., Commissioner                                                       October 19, 2010 U. S. Food and Drug Administration (FDA) 10903 New Hampshire Ave. Silver Spring MD 20993-0002 Subject:    Request that the FDA rescind its approval for Gardasil™ as a vaccine to prevent cervical cancer or to prevent genotype-specific human […]

[Continue reading...]

SANE Vax to Jack Stapleton, Chairman VRBPAC (vaccines and related biological products advisory committee)

By Leave a Comment

  October 19, 2010 Jack Stapleton, M.D., Chair  Vaccines and Related Biological Products Advisory Committee  University of Iowa Hospital Clinic  200 Hawkins Drive  Iowa City, Iowa 52242 SUBJECT:  Valid endpoint and reliable HPV genotyping for expanded use   proposal of GardasilTM vaccine Dear Dr. Stapleton: S.A.N.E. Vax, Inc. is a non-profit organization established to promote safe, […]

[Continue reading...]

Particles in Injections: What about the Patient?

By Leave a Comment

From a mother: A while ago I wrote this about particles in injections after vaccine stoppers are punctured: PARTICLES IN INJECTIONS – WHAT ABOUT THE PATIENT? It is generally recognized that particles in injections may result in serious complications for patients. The potential serious adverse events resulting from the use of a sterile injectable product […]

[Continue reading...]

Letter to Senator Barbara Mikulski: HPV Vaccine Concerns

By Leave a Comment

The following letter was sent by Dr. William Reichel, Georgetown University School of Medicine: Senator Barbara Mikulski 503 Hart Senate Office Building Washington, DC 20510 c/o Deborah_Moldover@Mikulski.senate.gov June 12, 2011 Dear Senator Mikulski, As a physician and past researcher at the National Institute of Health (NIH), I am writing to your office because of my […]

[Continue reading...]

News

Videos

Contact